Infliximab

    Infliximab — package

    info General information

    Name Infliximab, 100 mg, lyophilisate for concentrate for solution for intravenous infusion
    INN Infliximab
    Active substance Infliximab
    Pharmacotherapeutic group Immunosuppressants. Tumor necrosis factor-alpha inhibitors. Infliximab.
    Dosage form Lyophilisate for concentrate for solution for intravenous infusion.
    Packaging

    100 mg of infliximab in vials. 1 vial is placed in a cardboard box.

    Manufacturer Karaganda Pharmaceutical Complex LLP EU GMP

    assignment_turned_in Indications

    • Rheumatoid arthritis
    • Crohn's disease in adults, children and adolescents
    • Ulcerative colitis in adults, children and adolescents.
    • Ankylosing spondylitis.
    • Psoriatic arthritis.
    • Psoriasis